Skip to main content

RAD December 2021 Conference Abstracts and Posters

All accepted abstracts will be published in the British Journal of Dermatology.

620 - IL-13 and IL-4 Promote Proliferation and mRNA Expression of MUC2 and MUC5AC in Primary Human Conjunctival Goblet Cells

Maxim A.X. Tollenaere, Pernille Rævdal, Steffen Nagstrup, Anne Heegaard, Mads Roepke, Shannon Schneider, Hanne Norsgaard, Jacob P. Thyssen, Miriam Kolko


623 - Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis

Emma Guttman-Yassky, Ana Pavel,1Kenji Kabashima, Delphine Staumont-Salle, Kilian Eyerich, Walter Nahm, Sylvia Pauser, Joel Correa Da Rosa, Mads Roepke, Petra Amoudruz, Shannon Schneider, Andrew Blauvelt, Kristian Reich


626 - CONTENT VALIDITY AND ASSESSMENT OF THE PSYCHOMETRIC PROPERTIES AND SCORE INTERPRETATION OF A SLEEP-LOSS SCALE SCORE IN ATOPIC DERMATITIS

Gil Yosipovitch, Alissa Rams, Jessica Baldasaro, Laurine Bunod, Laure Delbecque, Sara Strzok, Juliette Meunier, Hany Elmaraghy, Luna Sun, Evangeline Pierce


627 - Examining the association of sleep disturbances with older adult age in atopic dermatitis patients

Jaya Manjunath, BS and Jonathan I. Silverberg, MD, PhD, MPH


632 - Epidemiology and burden of atopic dermatitis involving the head, neck, face, and hand: a cross sectional study from the TARGET-DERM AD cohort

Jonathan I Silverberg, Brenda Simpson, Katrina Abuabara, Emma Guttman-Yassky, Brian Calimlim, Colleen Wegzyn, Whitney Krueger, Amy Gamelli, Breda Munoz, Janet S Hildebrand, Julie M Crawford, Lawrence F Eichenfield, on behalf of TARGET-DERM Investigators


634 - Lebrikizumab Directly Reverses IL-13 Driven Neuronal Gene Regulation and Neuronal Excitability

Yannick Miron, Paul E. Miller, Chloe Hughes, Ethan A. Lerner (Presenter), Ferda Cevikbas


638 - Improvement in Patient-Reported Symptoms and Quality of Life With Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Who Received Background Topical Therapy: Results of a 26-Week, Randomized, Head-to-Head Trial

Jacob P. Thyssen, H. Chih-ho Hong, Marjolein de Bruin-Weller, Roland Aschoff, April W. Armstrong, Raj Chovatiya, Christian Vestergaard, Ricardo Rojo, Hernan Valdez, Fan Zhang, Ankur Bhambri, Daniela E. Myers, Kimberly Watson, Erman Guler, Claire Clibborn, Marco DiBonaventura


639 - Rapid and Sustained Improvement in Skin Pain With Abrocitinib in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis

Jacob P. Thyssen, Anthony Bewley, Sonja Ständer, Brian Kim, Pinaki Biswas, Marco DiBonaventura, Melissa Watkins, Justine Alderfer, Erman Guler, Jonathan I. Silverberg


641 - The Use of Digital Health Technology to Measure Nocturnal Scratch and Sleep in Atopic Dermatitis: Response to Abrocitinib

Yao Zhang, Junrui Di, Yiorgos Christakis, Nikhil Mahadevan, Jonathan Bruno, and Carrie A. Northcott


642 - Long-Term Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Who Had Failed or Were Intolerant to Oral Non-Steroidal Immunosuppressants: Pooled Analysis of JADE Clinical Trials

Michael Ardern-Jones, Mahreen Ameen, Marjolein de Bruin-Weller, Eric Simpson, Wing Sin Chiu, Pinaki Biswas, Gary Chan, Christopher Koulias, Stephan Weidinger


Page 3 of 7
Results 21 - 30 of 66